| dc.contributor.author | Sarris J | en_US |
| dc.contributor.author | Kavanagh Dj | en_US |
| dc.contributor.author | Adams Jon | en_US |
| dc.contributor.author | Bone K | en_US |
| dc.contributor.author | Byrne G | en_US |
| dc.contributor.editor | en_US | |
| dc.date.accessioned | 2012-02-10T06:09:34Z | |
| dc.date.available | 2012-02-10T06:09:34Z | |
| dc.date.issued | 2009 | en_US |
| dc.identifier | 2010003355 | en_US |
| dc.identifier.citation | Sarris J et al. 2009, 'Kava Anxiety Depression Spectrum Study (Kadss): A Mixed Methods Rct Using An Aqueous Extract Of Piper Methysticum', Churchill Livingstone, vol. 17, no. 3, pp. 176-178. | en_US |
| dc.identifier.issn | 0965-2299 | en_US |
| dc.identifier.other | C1 | en_US |
| dc.identifier.uri | http://hdl.handle.net/10453/17062 | |
| dc.description.abstract | Objectives: To report on the design, significance and potential impacts of the first documented human clinical trial assessing the anxiolytic and thymoleptic efficacy of an aqueous mono-extract of Piper methysticum (kava). The significance of the qualita | en_US |
| dc.language | en_US | |
| dc.publisher | Churchill Livingstone | en_US |
| dc.relation.isbasedon | http://dx.doi.org/10.1016/j.ctim.2009.01.001 | en_US |
| dc.title | Kava Anxiety Depression Spectrum Study (Kadss): A Mixed Methods Rct Using An Aqueous Extract Of Piper Methysticum | en_US |
| dc.parent | Complementary Therapies In Medicine | en_US |
| dc.journal.volume | 17 | en_US |
| dc.journal.number | 3 | en_US |
| dc.publocation | Edinburgh | en_US |
| dc.identifier.startpage | 176 | en_US |
| dc.identifier.endpage | 178 | en_US |
| dc.cauo.name | NMH.Faculty of Nursing, Midwifery and Health | en_US |
| dc.conference | Verified OK | en_US |
| dc.for | 110400 | en_US |
| dc.personcode | 0000068322;0000065721;112076;0000068326;0000068323 | en_US |
| dc.percentage | 000100 | en_US |
| dc.classification.name | Complementary and Alternative Medicine | en_US |
| dc.classification.type | FOR-08 | en_US |
| dc.edition | en_US | |
| dc.custom | en_US | |
| dc.date.activity | en_US | |
| dc.location.activity | ISI:000266422600009 | en_US |
| dc.description.keywords | Disorder; Efficacy; Metaanalysis; Prevalence | en_US |
| dc.staffid | en_US |